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Chitosan microspheres can address challenges associated with poor bioavailability or 
unsustained drug release when used as drug delivery systems thanks to their 
mucoadhesiveness, which allows the drug dosage to be retained in the gastrointestinal 
track for extended periods. Chitosan-3-glycidoxypropyltrimethoxysilane-β- 
glycerophosphate (chitosan-GPTMS-β-GP) hybrid microspheres were synthetized 
through sol-gel processing using a microfluidic approach. Microspheres with uniform 
spherical shapes and sizes of approximately 650 µm were obtained. The microstructures 
of the microspheres consisted of four different siloxane structures. The degradation 
behaviors of the hybrid microspheres were examined under acidic pH conditions 
mimicking those found in the gastrointestinal track. Microspheres with different 
GPTMS molar ratios were incubated under several pH conditions for 2 weeks. The 
microspheres incubated at pH 7.4 extended the lowest weight loss (27%-32%), whereas 
those incubated at pH 1.7 and pH 5.4 showed greater weight losses of 43-59% and 69-
77%, respectively. The inhibition of the degradation at low pH was dependent on the 
siloxane network in the chitosan matrix. Phosphate was mostly released in early stages, 
and the released amount of silicon was dependent on the composition. GPTMS was 
released with a chitosan chain via the hydrolysis of a chitosan molecule. The 
pelargonidin was incorporated in the microspheres and the slow releasing was observed 
at acidic condition. The resistance of these hybrid microspheres to low-pH conditions 
for longer than a full digestion cycle is promising for gastrointestinal drug delivery 
applications.
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1. Introduction
Biodegradable microspheres have presented several advantages compared with 
conventional delivery systems. For instance, they offer a more sustained and controlled 
release of drugs over time, thereby reducing the need for multiple doses and allowing 
the release of insoluble drugs [1,2]. Moreover, both synthetic and natural polymers are 
normally cleaved into biocompatible byproducts, resulting in no bodily harm [3]. Even 
though microspheres are small, they have large surface area to volume ratios [1,2]. The 
synthesis of microspheres with good size uniformity has been reported when using a 
microfluidic approach [4,5]. This method is simple and has the advantage of using small 
solution volumes. 
Organic-inorganic hybrids that involve natural biodegradable polymers such as 
chitosan, are studied by researchers in the form of scaffolds, films, hydrogels and 
spherical particles. In particular, the organic-inorganic hybrid hydrogels are suitable 
candidate for drug carrier controlled the releasing [6-8]. Chitosan is a natural polymer 
that consists of polysaccharide chains. The biocompatible, bioresorbable, 
mucoadhesive, non-toxic and non-antigenic [9-11] properties of chitosan make it a 
suitable candidate for medical applications. Additionally, chitosan-mediated systems 
can considerably improve the bioavailability across the epithelial layer of the oral cavity 
[12] and gastrointestinal track [13]. However, this polymer lacks mechanical endurance 
and a controlled degradation rate [1]. To overcome these disadvantages, non-toxic 
crosslinking agents are required. Shirosaki et al. assessed the cytotoxicity of several 
crosslinking agents for chitosan, 3-glycidoxypropyltrimethoxysilane (GPTMS) 
monomer proved to be less cytotoxic than glutaraldehyde for MG63 human 
osteosarcoma cells [14]. The chitosan-GPTMS hybrids are degradable with a 
controllable degradation rate because the crosslinking ratio and formation of a Si-O-Si 
network. The grafting of Si-OH groups or Si-O-Si networks into the polymer also 
induces bioactive properties. However, this precursor requires pH neutralization for 
application in the human body. β-glycerophosphate (β-GP) is a weak base and one of 
the osteogenic supplements used for the cultures of human bone marrow mesenchymal 
stem cells. Chenite et al. [15] prepared injectable hydrogels using chitosan–β-GP and 
reported their good cartilage tissue regeneration. Shirosaki et al.[16] reported that 
MG63 cells exhibited good cytocompatibility on chitosan-GPTMS-β-GP hydrogels 
compared with the chitosan-β-GP system.
Assessment of the degradation behavior of a biomaterial is essential. The human body 
presents a diverse range of pH levels. The normal range pH reference of arterial blood is 
7.35 to 7.45 [17-19]. In contrast, the pH in the stomach of healthy people in the second 
and third postprandial period varied from 1.7 to 4.3 [20]. Furthermore, the duodenal pH 
decreased from 6.1 to 5.4 when a meal is ingested [21].
In the present study, a microfluidic approach was used to synthesize chitosan-siloxane-
β-GP hybrid microspheres. Their structural composition was analyzed and the 
degradation behaviors were examined under several pH conditions; in addition, their 
stability and elemental release from the microspheres matrix were evaluated. The 
microspheres also incorporated pelargonidin as drug model and their releasing behavior 
was tested. Pelargonidin is one of the anthocyanins, which have an on the protection 
against a myriad of human diseases (prevention of cardiovascular and neuronal 
diseases, diabetes, etc.) by their antioxidant properties [22,23].
2. Materials and Methods
1. Preparation of chitosan-siloxane hybrid microspheres
Chitosan (high molecular weight, DA>75%, Sigma-Aldrich®) was dissolved in 0.1 M 
hydrochloric acid to attain a concentration of 2% (w/v). The chitosan solution was 
mixed in a planetary centrifugal mixer (ARE-310, Thinky, USA) at room temperature, 
followed by autoclaving at 121°C for 20 min and filtering (polyethersulfone, 0.22 μm 
pore) to obtain a homogeneous solution. An appropriate amount of GPTMS (97%, Alfa 
Aesar) was added to the chitosan solution, and the mixture was stirred at room 
temperature for 2 h. For 10 mL of chitosan-GPTMS, 3.25 mL of 2.5 M β-GP (pH 9.6, 
Sigma) was added at 0°C for 10 min to neutralize the precursor sol pH to 7. The 
microfluidic system consisted of two syringe pumps (YMC KeyChem), one containing 
the hybrid solution and the other containing the oil solution. Both syringes were 
connected to a Y-shaped microchannel (Fig. 1). The precursor sol was used as the 
dispersed phase, and an oily solution of 4% (w/v) span/squalene (Sigma-Aldrich®) was 
used as the continuous phase. When both solutions fused in the Y microchannel, the 
microspheres were formed. The optimized conditions used in the microfluidic system 
are listed in Table 1. Then the microdrops were gelated at 60°C for 1 h in 4% (w/v) 
span/squalene oil solution to obtain the wet microspheres. The wet microspheres were 
rinsed with a series of graded ethanol dilutions (100%, 90%, 80%, 70%, 60%, 50% and 
25%) to remove the oil. These microspheres were intended to be used for future 
biological characterization, therefore the microspheres were sterilized by autoclaving at 
121°C for 20 min in distilled water. To incorporate pelargonidin, pelargonidin chloride 
(Sigma-Aldrich®) was dissolved into 0.1 M HCl and then added into chitosan-
GPTMS solution to achieve the concentration of 1 mg/mL. After mixing for 20 
min at room temperature, the microspheres with pelargonidin were prepared as 
following above procedure.    
Table 1 Starting compositions of the hybrid microspheres and optimized parameters 
used in the microfluidic system. 
Molar ratio Flow rate (mL/min) Channel (mm)
Sample
Chitosan GPTMS Oil Sol Depth Width
Outlet 
(mm)
ChG10 1.0 1.0 0.100 0.005 1.0 0.8 1.0
ChG15 1.0 1.5 0.100 0.005 1.0 0.8 1.0
2. Structural characterization of the hybrid microspheres
The size and shapes of the microspheres were examined under a bright-field microscope 
(IX73, Olympus, Japan). ImageJ v1.48 software (National Institutes of Health, USA) 
was utilized to measure the diameter of more than 100 microspheres. The surface 
morphology of the microspheres was examined using SEM (JMS-6010 PLUS/LA, 
JEOL, Japan) equipped with an energy dispersive X-ray spectrometry (EDS) to detect 
the elements present in the microspheres at 15 kV operating voltage and a working 
distance of 10 mm. The samples were coated with a 15 nm thick layer of Pt/Pd using a 
magnetron-sputter coater (MSP-1S Magnetron Sputter, Vacuum Device Inc., Japan). 
The surface charge of the microspheres in phosphate buffered saline (PBS, pH7.4, 
Gibco) and in distilled water were measured via Zeta Potential (ELS-Z, Photal Otsuka 
Electronics, Japan) using the rectangular cell to determine the surface charge and 
potential stability. Solid-State 13C, 29Si, 31P, and 1H NMR measurements were 
performed on an Agilent DDS 500 MHz NMR spectrometer (Agilent Technologies, 
Inc., Santa Clara, CA, USA) operating at 11.7 Tesla. A zirconia rotor with a diameter of 
3.2 mm was used with an Agilent HXY T3-MAS probe. The rotor spinning frequency 
for magic angle spinning (MAS) was controlled to be 15 kHz. 1H→13C cross-
polarization (CP)-MAS NMR experiments were performed with contact time of 500 μs 
and recycle delay of 10 s, where the signals of 3700 and 5400 pulses were accumulated 
for ChG15 and ChG10, respectively, with adamantane (C10H16) as the external reference 
(38.52 ppm vs. 0 ppm TMS). In addition, 1H MAS NMR spectra were taken at 499.8 
MHz with a 1.15 μs pulse length (pulse angle, π/4) and 5 second recycle delays, where 
the signals of 8 pulses were accumulated with adamantane (C10H16) as the external 
reference (1.91 ppm vs. 0 ppm TMS). Furthermore, 1H→29Si CP-MAS NMR 
experiments were performed with contact time of 5 ms and recycle delay of 5 s, where 
the signals of 40580 and 79460 pulses were accumulated for ChG15 and ChG10, 
respectively, with polydimethylsilane (PDMS) as the external reference (-34.44 ppm vs. 
0 ppm TMS). Direct polarization 31P MAS NMR spectra were taken at 202.3 MHz 
where a 1.4 μs pulse length (π/4-pulse angle) and 120 second recycle delays using 
NH4H2PO4 as the external reference (1.0 ppm vs. 0 ppm 85% H3PO4). The signals of 
508 and 718 pulses were accumulated for ChG15 and ChG10, respectively. 1H high-
power decoupling was used during the 31P acquisition. 1H→31P CP-MAS NMR 
experiments were also performed with contact time of 1 ms and recycle delay of 5 s, 
where the signals of 1000 and 2720 pulses were accumulated for ChG15 and ChG10, 
respectively. Weight measurements were performed before and after drying at 100°C 
until the microspheres were completely dried. The following equation was used to 
determine the water content:
Water content (%) = (Ww - Wd)/Ww × 100 Eq. (1)
were, Ww and Wd represent the wet and dry weight, respectively.
3. Compression assay and thermogravimetric analysis
Compression tests (Rheoner II Creep meter RE2-3305C, Yamaden, Japan) were 
performed to evaluate the stress-deformation behavior of the microspheres under a 
uniaxial compressive load. A 20 N load was applied using a cylindrical probe with 3 
mm of diameter, and a descending speed of 0.05 mm/sec. The compression tests of 
individual microspheres were performed with replicates for both ChG10 and ChG15. 
Thermal decomposition of the samples was conducted with simultaneous recording of 
the weight loss using thermogravimetric analysis (TG) and differential thermal analysis 
(DTA) (TG-DTA 2000S, Mac Science, Co., Yokohama, Japan) with a heating rate of 
10°C/min in air from room temperature to 800°C.
4. Degradation assay under several pH conditions and drug releasing test at acidic 
condition
The 200 microspheres were incubated in solutions under three different pH conditions. 
According to the literature, the gastric juices secreted by parietal cells from the stomach 
consist of 0.1 M HCl [24,25]. Therefore, to mimic the gastric acid conditions, the 
microspheres were incubated in 0.1 M HCl solutions of pH 1.7 and 5.4 (adjusted with 
using 0.2 M NaOH) at 36.5°C (water bath) and agitated at 100 rpm for 14 days. For 
neutral pH condition, the same number of microspheres was incubated in PBS (pH 7.4) 
under the same conditions. At the designated time points, the surrounding excess 
soaking solution was removed using a pipette for weight measurements. The mass 
percentage retained in the microspheres was calculated by comparing the remaining 
weight with the initial weight using the following equation:
Weight loss (%) = (Wb - Wa)/Wb × 100 Eq. (2)
where, Wb and Wa represent the weights before soaked and after soaking, respectively. 
The supernatant was reserved for pH measurements (pH meter LAQUAtwin B-712, 
Horiba, Japan) and to evaluate the elements released from the microspheres matrix. 
Assessment of the phosphate and silicon released into the supernatant during the 
degradation assays was performed using inductively coupled plasma atomic emission 
spectrometer (ICP-AES; ICPE-9820, Shimadzu, Japan). The surface morphology after 
the degradation tests was also examined using SEM. To determine the potential changes 
in the sample crystallinity after degradation, the microspheres were examined by 
powder X-Ray Diffraction (XRD, MXP3V, Mac Science, Co., Yokohama, Japan) with 
CuKα radiation. The scanning were performed for the 2θ angle ranging from 5.020° to 
40.000° with a step size of 0.020°, a counting time of 1 s, an operating voltage and 
current of 40 kV and 30 mA, respectively. The microspheres with pelargonidin were 
soaked in 0.1 M HCl of pH 1.7 at 37°C. Sample solutions with or without the 
microspheres without pelargonidin were also incubated as control condition. The optical 
absorbance of the supernatant was recorded with an UV-VIS spectrophotometer 
(DeNovix, DS-11+, DeNovix Inc.) at the highest peak around 225-230 nm. After 
measuring, the supernatant was inserted again into the respective tube and continued the 
releasing test.
5. Statistical analysis
The results were analyzed using one-way analysis of variance (ANOVA) followed by 
Tukey’s test with a significance level of p<0.05. The statistical analysis was performed 
using GraphPad Prism (GraphPad Prism Software version 6, CA, United States).
3. Results and Discussion
3.1 Synthesis of microspheres by microfluidic system and their microstructure
The production of the chitosan and chitosan-β-GP without GPTMS was attempted as 
control but the microspheres were not obtained due to the slow gelation time. Therefore, 
GPTMS plays an essential role in the synthesis of the microspheres using the 
microfluidic system. To size uniformity of microparticle is an important parameter, 
especially if they are applied as drug carriers. The hybrid microspheres fulfilled the size 
uniformity requirement, and the obtained size was adequate for gastrointestinal drug 
delivery because it avoids internalization by 
gastric cells. Indeed, some researchers [26,27] 
reported the use of microparticles for 
gastrointestinal drug delivery with sizes ranging 
from 400-1000 μm with good drug entrapment efficiency. Using the optimized 
microfluidic conditions reported in Table 1, monodispersed microspheres with uniform 
size were obtained (Fig. 2), specifically size of 638±15 µm for ChG10 and 661±23 µm 
for ChG15. In addition, the produced microspheres had a spherical morphology 
regardless of the molar ratio composition. As observed in previous studies [16], higher 
GPTMS content resulted in a decrease of the gelation time of the hybrid solution into 
hydrogels. Consequently, the highest molar ratio used was chitosan:GPTMS=1:1.5; 
above this ratio, premature gelation of the hybrid solution rapidly occurred in the 
syringe and microchannel. This gelation led to a higher solution viscosity, which 
disrupted the flow rate of the solutions, hindering the continuous and long-term 
production of microspheres. ChG10 and ChG15 contained different amounts of water 
depending on the GPTMS molar ratio used; for instance, ChG10 contained 87.5% 
water, whereas ChG15 only contained 59.1% water. The lower water content in the 
ChG15 microspheres was expected because of the increase of GPTMS content in 
ChG15 compared with ChG10. This reduced water content led to higher crosslinking 
with the chitosan backbone as well as higher condensation of the Si-O-Si network [14], 
which affected the water content in the matrix of the microspheres. Fig. 3 shows the 
SEM images of the ChG10 surface. The particles were spherical, even after being dried. 
Their surface topography was rugged with nanosize pores regardless of the 
composition. The majority of microscopic materials in contact with a liquid suspension 
tend to acquire an electronic charge on the material surface [28]. The zeta potential is an 
indicator of the charge and potential stability of the colloidal system. A greater zeta 
potential indicates greater stability of the suspension due to the repulsion between 
charged particles, therefore overcoming the tendency to aggregate that occurs as zeta 
approaches zero [29]. Ideally, particles with zeta values greater than +30 mV or more 
negative than -30 mV are considered more stable. However, these values can be affect 
by the ionic strength and pH, among other factors. Therefore, the zeta potential cannot 
be considered to exclusively to determine the stability of the system. The hybrid 
particles presented zeta potential values closer to 30 or -30 mV or half of those values. 
In distilled water, ChG10 and ChG15 exhibited zeta potential values of 33.68±1.84 mV 
and 15.59±2.38 mV, respectively. Whereas, in PBS, ChG10 and ChG15 exhibited 
values of -13.80±1.49 mV and -27.41±0.92 mV, respectively. Consequently, the surface 
charge of the hybrid microspheres differed depending on the solution on which they 
were dispersed suggesting that they tend to interact with ions from the solution. Thus, 
the negative charge could be due to the interaction of the microspheres with the 
phosphate ions from PBS. Fig. 4 shows 13C CP-MAS-NMR and 31P DD-MAS-NMR 
spectra of the ChG10 and ChG15 microspheres. Based on previous study [16], the 
peaks were assigned to C-1 to C-6, N-acetyl C=O, and N-acetyl-methyl CH3 signals 
from chitosan and Cb and Ca from GPTMS. Moreover, two signals of β-GP overlapped 
with those of C-5,3 and C-6. The presence of Cβ appeared as an increase of the intensity 
of the C-6 peak. The 31P peaks for the hybrid microspheres were clearly detected at 4.7 
ppm for ChG15 and were sharper than those at 5.0 ppm for ChG10. Fig. 5 presents the 
29Si CP-MAS-NMR spectra of the ChG10 and ChG15 microspheres. The signals were 
deconvoluted into four close peaks near -39, -49, -57 and -66 ppm corresponding to the 
T0, T1, T2 and T3 species, respectively. The number of Si-O-Si bridging bonds per Si 
atom represents the degree of polymerization of the -Si-OH or -Si-OR groups at the end 
of the GPTMS molecules and can therefore be calculated using the following equation:
Degree of polymerization 
= [(fraction of T1) × 1] + [(fraction of T2) × 2] +[ (fraction of T3) × 3] Eq. (3)
The number of Si-O-Si bridging bonds per Si atom derived from the relative peak area 
of each Tn unit, increased from 2.24 for ChG10 to 2.34 for 
ChG15, as shown in Table 2. The condensation of GPTMS 
was accelerated by the amount of GPTMS similar to a 
previous result [16]. The NMR results indicate the 
remaining Si-OH is related to water content in the 
microspheres.
Table 2 29Si chemical shifts (δ (ppm)), full width at half maximum (FWHM (ppm)), and 
relative peak area (I (%)) for T units derived from 29Si CP-MAS NMR spectra.
T unit T0 T1 T2 T3 Nbo/Si
sample δa FWHMb Ic δa FWHMb Ic δa FWHMb Ic δa FWHMb Ic
ChG10 -39.1 4.3 3.1 -48.8 5.8 14.7 -57.5 6.2 37.3 -66.4 6.8 44.9 2.24
ChG15 -38.9 3.5 1.9 -48.7 5.1 10.9 -57.6 6.0 38.5 -66.5 6.8 48.7 2.34
a The estimated error of the chemical shifts was less than ±0.1 ppm.
b The estimated error of the FWHM was less than ±0.2 ppm.
c The estimated error of the relative peak area was less than ±0.3%.
3.2 Compressive strength and thermal behavior
The stress-deformation behaviors of the ChG10 and ChG15 samples are shown in Fig. 
6. Repeated tests were performed, and for each condition, the replicates exhibited 
almost overlapping behaviors. At the maximum elastic-plastic loading, the limit stress 
of both the ChG10 and ChG15 microspheres was approximately 15 MPa (Fig. 6a) 
without regaining their original shape. Starting from approximately 20 % distortion, the 
stress values of the ChG10 samples were slightly higher than those for ChG15. 
Therefore, at the 50 % distortion point (Fig. 6b), the averages of the replicates were 
compared, and a statistical difference was observed between ChG10 and ChG15. This 
difference could be due to the higher water content and the Si-OH in the matrix of 
ChG10 microspheres. Fig. 7 shows the TG-DTA curves of the original chitosan flakes, 
GPTMS monomer, and hybrid microspheres. In general, up to 260°C, a first stage 
attributed to the vaporization of moisture was observed for all the samples, and all the 
DTA peaks were exothermic. For the chitosan curve, the weight loss occurred from 
251°C to 588°C in two phases after vaporization. The weight loss at each step was 32% 
and 37%, respectively. Chitosan displayed a very broad and round DTA curve. The first 
stage was associated with the thermal degradation of the polymeric chain with 
vaporization of volatile compounds [30]. The pyrolysis of the polysaccharides begins 
with the fragmentation of the glycosidic links and is associated with weight loss from 
the non-acetylated and acetylated units of the polymer [31,32]. The second stage of 
degradation was related to the residual decomposition of chitosan [30,33]. The curve of 
the GPTMS monomer had a steep slope starting at 159°C until 215°C with a remaining 
weight of 5%. The steep slope is associated with the degradation of the organic chains 
of the GPTMS (CH2 and CH), because the reference boiling point of GPTMS is 120°C 
(2 mmHg). One additional stage appeared for the weight loss of the microspheres 
compared with chitosan with the existence of a noticeable DTA curvy peak at 560°C 
and 580°C. In terms of mass loss, ChG10 lost approximately 13% from 274°C to 
316°C, 18% to 554°C with a final slope of 19% mass loss. Similarly, the ChG15 
microspheres underwent mass losses of approximately 18% from 261°C to 311°C, 25% 
to 537°C, and 20% in the final stage.
3.3 Degradability of hybrid microspheres under several pH conditions
Fig. 8a-c shows the weight loss (%) of the hybrid microspheres under 1.7, 5.4 and 7.4 
pH conditions. The pH7.4 series exhibited the lowest weight losses of 27% for ChG10 
and 32% for ChG15. Although degradation of the microspheres occurred faster in the 
pH 5.4 and pH 1.7 series, the weight losses of ChG10 of ChG15 were 43% and 59%, 
respectively, for pH1.7 and 77% and 69%, respectively, for pH5.4. Generally, chitosan 
can dissolve well in a weak acid near pH 4.5-6.4. However, the chitosan-GPTMS 
microspheres were gradually degraded and remained after 14 days even at pH 5.7. The 
observed weight loss pattern might be beneficial for drug delivery applications (e.g. 
insoluble drugs, proteins or peptides), because the nutrient adsorption substantially 
occurs in the duodenum continuing throughout the small intestines [34]. Monitoring the 
pH helps to understand the degradation and stability of the particles and predict passive 
or possible harmful effects when they are in contact with living tissues, i.e., a very 
drastic pH imbalance to acidic conditions can create a detrimental effect. 




(days) pH 1.7 pH 5.4 pH 7.4 pH 1.7 pH 5.4 pH 7.4
7 1.7±0.0 6.2±0.0 7.3±0.1 1.8±0.1 6.2±0.0 7.3±0.1
14 1.7±0.0 6.4±0.1 7.2±0.1 1.7±0.0 6.4±0.1 7.3±0.1
Table 3 summarizes the pH changes during the 14 days. Under pH 1.7 and 7.4 
conditions, both ChG10 and ChG15 were stable with almost no deviation from the 
initial pH. For pH 5.4, an increase in the pH was observed mostly at 7 days with a final 
pH after 14 days of 6.4. Fig.9 and Fig.10 show the released amount of phosphorus and 
silicon from the microspheres in solutions with different pH values. The released 
amount of phosphorus increased within 14 days. After 14 days, nearly all the samples 
had released similar amounts of 0.0421 mM regardless of the pH. For the silicon, the 
released amount also increased with the soaking time. The ChG15 series released more 
silicon than the ChG10 series. In addition, more silicon was released at pH 1.7. The 
phosphate release depended on the composition and the surface charge because of the 
weak electrostatic chemical interaction between the negatively charged phosphate 
molecules from β-GP (-PO42- or -HPO4-) and positively charged chitosan (-NH3+) [33]. 
The amino groups of ChG15 were crosslinked with GPTMS more than ChG10, 
preventing the amino groups from interacting with the phosphate groups. Therefore, 
without interaction with amino groups, the residual β-GP was easily released. The 
released amount of silicon depends on the crosslinked amount with amino groups 
because silicon released with chitosan chains. SEM micrographs of the dried 
microspheres after 14 days of degradation at pH 5.4 are presented in Fig.11. After 14 
days, there were no dramatic signs of severe surface deterioration for most of the pH 
conditions, however, the ragged surface became slightly smooth. The spherical shape 
was only lost for the 5.4 pH series after 14 days because the degradation. The XRD 
spectra in Fig. 12 confirms the chitosan skeleton degradation with the loss of the peak at 
2θ=20° (corresponding to (022) and (102) planes, ICDD #39-1894) for the ChG10 
microspheres after 14 days under several pH conditions. However, the pH 7.4 series still 
showed a very weak peak and was close to becoming amorphous. The degradation 
results suggested the following degradation steps. (1) β-GP interacted with chitosan 
released. (2) The chitosan matrix was relaxed, and the solution entered the space, 
resulting in a reduction of the chitosan crystallinity. (3) Finally, the chitosan molecule 
was hydrolyzed to form fragments and the crosslinked 
siloxane units were also released with the chitosan 
fragments from the microspheres. Therefore the 
amount of released silicone corresponded to the 
composition of the microspheres. Moreover, the 
degradation of the microspheres from the surface observed using SEM was confirmed.
For the microspheres to be used as drug delivery systems for the gastrointestinal track, it 
is important to consider the effects of the chitosan, phosphorus, and silicon released and 
the limit tolerated by the body without side effects. Considering that chitosan has been 
approved as a food additive by regulatory entities such as the FDA, the uptake of 
degradation products from chitosan is considered safe for the body. Phosphorus plays a 
crucial biological role in the health of bones, and the concentration in serum varies with 
age; in infants, the normal range is 1.50-2.65 mM, and in adults, the normal range is 
0.8-1.5 mM [34]. However, Van Dyck et al. [37] stated that the average concentration 
of silicon in sera in healthy Belgians (including pregnant women) was approximately 
4.24 mM. Therefore, the maximum amount of both element released from the hybrid 
microspheres were very low, suggesting no harmful effect to the human body.
Figure 13 showed the release profile of pelargonidin from ChG15 microspheres within 
24 h in SGF. The pelargonidin release occurs mainly within the first 2 hours of 
incubation. The rapid release within 2h is ascribed to a simple diffusion. After 2 hours, 
a plateau period was observed. Figure 14 showed images of the samples after 24 hours 
incubation. The microspheres are still colored by pelargonidin. The results suggested 
that the pelargonidin can be released at acidic condition very slowly following the 
degradation of the microspheres.  
4. Conclusion
Chitosan-siloxane hybrids microspheres were successfully synthesized using a 
microfluidic approach via sol–gel process with β-GP as the neutralizing agent. The 
microspheres had uniform spherical shapes with sizes of approximately 650 μm. 
Crosslinking with GPTMS inhibited chitosan degradation even at low pH, and the 
spherical shapes were maintained after 14 days of degradation. Siloxane networks were 
formed in the chitosan matrix and condensation was promoted by the GPTMS content. 
Phosphate was easily released because of its weak interaction with chitosan. However, 
the amount of silicon released with chitosan degradation was dependent on the 
composition of GPTMS. These microspheres withstood harsh pH conditions for 14 
days, which is longer than the time needed to complete a full digestion cycle. Moreover, 
the slow drug releasing was expected with the microspheres at acidic condition. 
Therefore, the result suggests that the synthesized hybrid microspheres are appropriate 
for use as drug delivery systems for the gastrointestinal track via oral administration.
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Figure captions
Fig. 1 Schematic representation of the shape and dimensions of the microchannel and 
microspheres before the gelation.
Fig. 2 Brightfield images (obj. 4×) of ChG15 microspehres after gelation.
Fig. 3 SEM images of ChG10 dried microspheres before degradation test. b) is a 
magnified view of a).
Fig. 4 a) 13C CP-MAS-NMR and b) 31P DD-MAS-NMR spectra of ChG10 and ChG15 
microspheres; the corresponding signals are labeled with the chemical 
structures.
Fig. 5 29Si CP-MAS-NMR spectra of ChG10 and ChG15 microspheres; the 
corresponding signals are labeled with the chemical structures.
Fig. 6 Compression test results of ChG10 and ChG15 samples. a) ChG10 and ChG15 
behavior under uniaxial compression force. b) Stress average of 3 replicates for 
both microspheres at the same distortion point. * represents a significant 
difference between ChG10 and ChG15 at the same distortion point (p<0.05).
Fig. 7 a) TG and b) DTA curves of chitosan flakes, GPTMS monomer, and ChG10 and 
ChG15 microspheres.
Fig. 8 Weight loss of ChG10 and ChG15 microspheres over 14 days at 37°C; a) pH 1.7, 
b) pH 5.4, and c) pH 7.4. * represents a significant difference between ChG10 
and ChG15 at the same distortion point (p<0.05).
Fig. 9 Phosphorus concentration released from ChG10 and ChG15 microspheres over 
14 days at 37°C; a) pH 1.7, b) pH 5.4, and c) pH 7.4. * represents a significant 
difference between ChG10 and ChG15 at the same distortion point (p<0.05).
Fig. 10 Silicon concentration released from ChG10 and ChG15 microspheres over 14 
days at 37°C; a) pH 1.7, b) pH 5.4, and c) pH 7.4. * represents a significant 
difference between ChG10 and ChG15 at the same distortion point (p<0.05).
Fig. 11 SEM images of ChG10 and ChG15 dried microspheres after 14 days 
degradation test at pH 5.4. c) and d) are magnified view of a) and b), 
respectively.
Fig. 12 XRD patterns of chitosan flake, and ChG10 microspheres before and after 14 
days degradation test under several pH conditions.
Fig. 13 Releasing profile of pelargonidin from the microspheres (ChG15) in SGF 
(pH1.7) at 37°C up to 24 hours.















Table 1 Starting compositions of the hybrid microspheres and optimized parameters 
used in the microfluidic system. 
Molar ratio Flow rate (mL/min) Channel (mm)
Sample
Chitosan GPTMS Oil Sol Depth Width
Outlet 
(mm)
ChG10 1.0 1.0 0.100 0.005 1.0 0.8 1.0
ChG15 1.0 1.5 0.100 0.005 1.0 0.8 1.0
Table 2 29Si chemical shifts (δ (ppm)), full width at half maximum (FWHM (ppm)), and 
relative peak area (I (%)) for T units derived from 29Si CP-MAS NMR spectra.
T unit T0 T1 T2 T3 Nbo/Si
sample δa FWHMb Ic δa FWHMb Ic δa FWHMb Ic δa FWHMb Ic
ChG10 -39.1 4.3 3.1 -48.8 5.8 14.7 -57.5 6.2 37.3 -66.4 6.8 44.9 2.24
ChG15 -38.9 3.5 1.9 -48.7 5.1 10.9 -57.6 6.0 38.5 -66.5 6.8 48.7 2.34
a The estimated error of the chemical shifts was less than ±0.1 ppm.
b The estimated error of the FWHM was less than ±0.2 ppm.
c The estimated error of the relative peak area was less than ±0.3%.




(days) pH 1.7 pH 5.4 pH 7.4 pH 1.7 pH 5.4 pH 7.4
7 1.7±0.0 6.2±0.0 7.3±0.1 1.8±0.1 6.2±0.0 7.3±0.1
14 1.7±0.0 6.4±0.1 7.2±0.1 1.7±0.0 6.4±0.1 7.3±0.1
